All News

URI.infection.COrona.jpg

Rheumatic Patients Are at Risk for COVID Death

MedPage Today

Patients with rheumatic diseases who developed COVID-19 were at increased likelihood of death, with risk factors similar to those seen in the general population but also because of factors specific to their underlying disease and its treatment, analysis of data from an international registry foun

Read Article
RheumNow Podcast square

RheumNow Podcast – Pounds of Prevention (3.5.2021)

Jack Cush, MD

Dr. Jack Cush reviews and discusses nearly a dozen news reports and journal articles from the past week on RheumNow.com.

Read Article
Telemedicine.MD.Computer.phone (keep)

Paucity of Effectiveness Research on Telemedicine in RA

Jack Cush, MD

A systematic review of telehealth in delivering equivalent care in RA patients demonstrates there is limited evidence that virtual RA care is equivalent to conventional face-to-face care. Despite current widespread use, there is a great need for credible well-designed research that will address comparable patient outcomes, implementation strategies and long‐term health system consequences. 

Read Article
COVID Vaccine Rebuttals by Dr. Kathryn Dao ( @KDAO2011) Dr. Dao addresses the common vaccine concerns that have been posed to her and her rebuttals. https://t.co/f5gwBICEGy https://t.co/Nzm1HfY5GW

Links:

Dr. John Cush RheumNow ( View Tweet)
RheumNow Podcast – Listener Questions https://t.co/LXW8uyFGNP

Links:

Dr. John Cush RheumNow ( View Tweet)

Listen to last weeks QD Clinics Podcasts (Mar 12)-Ms. RA, Notalgia & Anti-Intraarticular QD147 - Combination Biologics QD146 - Anti-Intraarticular QD145 - Notalgia? QD144 - Ms. RA QD143 - Blinded by Noncompliance https://t.co/UgE54RqFHQ

Links:

Dr. John Cush RheumNow ( View Tweet)

Population claims based study of RA patients shows improvement in the 10-year risk of acute myocardial infarction over time (same as the general population). Nevertheless, RA pts have a 21 % higher risk of AMI than the matched general population https://t.co/zfsJftR9ZA

Links:

Dr. John Cush RheumNow ( View Tweet)

Analysis of US National Inpatient Sample (2000‐2014). In #RA pts, there was a signif decline in annual rate of hospitalizations (76per million in 2000 to 30 per million 2014) & Hosp mortality (0.70% to 0.41%); but a signif incr in hosp for arthroplasty https://t.co/kkpmdKzEhQ

Links:

Dr. John Cush RheumNow ( View Tweet)

75 RA pts on MTX >3 yrs had FIBROSCANS done to assess their value. 12 pts (16%) had Fibroscan ≥ 7.1 kPa, 3 patients w/ severe liver stiffness (9.5 to 12.5 kPa) & 1 w/ cirrhosis range scores (> 12.5 kPa). No Bx were done; LFTs were not predictive https://t.co/Pi1h1nF0Uq

Links:

Dr. John Cush RheumNow ( View Tweet)

QD Clinic - RA and LFTs NAFLD, NASH and Risks with DMARDs and MTX https://t.co/LYV9WycEjz https://t.co/CMGtU4vclY

Links:

Dr. John Cush RheumNow ( View Tweet)
#RA associated interstifial lung dz has incidence of 1-5 per 1,000 PYs and prevalence as high as 67%; risk factors; age, male sex, Dz duration, CCP Abs; w/ age as best predictor of mortality. There is no clear drug interventions that helps RA-ILD https://t.co/zJvWqt0w6L

Links:

Dr. John Cush RheumNow ( View Tweet)

Download available--Difficult RA Defined https://t.co/6WGMEiwiUk

Links:

Dr. John Cush RheumNow ( View Tweet)

News Feature: Paucity of Effectiveness Research on Telemedicine in RA https://t.co/AoKnIZCYgA https://t.co/MCBfVoEvBX

Links:

Dr. John Cush RheumNow ( View Tweet)
While RA incurrs a 2 fold risk of CHF; the use of HCQ does not add to a CHF risk. Mayo nested case-control study, compared RA w/ CHF vs nonCHF RA pts, showing HCQ use, nor duration of use, failed to increase CHF (OR: 0.96).https://t.co/Tx9jr07C7i

Links:

Dr. John Cush RheumNow ( View Tweet)

620 RA patients from Nordic biologics registers started a non-TNFi as 1steverr bDMARD but later switched to a 2nd bDMARD (ABA 86, RTX 40, TCZ 67 TNFi 427). Retention was 70% @ 6 mos & 50% @12 mos. 30-40% on 2nd bDMARD reached LDAS or remission https://t.co/u8BQn0rYca

Links:

Dr. John Cush RheumNow ( View Tweet)

Compared with no statin use; statin use in RA pts is assoc w/ 28% lower mortality risk. Population study of 19,614 RA pts w/ incident statin use, compared 1,883 statin users vs 1,883 nonusers. All-cause mortality was lower (HR 0.72;0.56-0.91) w/ statins https://t.co/onMlWoVdPL

Links:

Dr. John Cush RheumNow ( View Tweet)

News Feature: Measureable Benefits to Treat-to-Target Management in RA https://t.co/iAvLWJGTXp https://t.co/NfNj3MWznI

Links:

Dr. John Cush RheumNow ( View Tweet)
Pooled analysis of 16 observational RA registries (27 583 patients) shows that seropositivity was associated with better remission, LDAS and withdrawal rates for RTX and ABA, but not TNF inhibitors. https://t.co/aNphJpB7JB

Links:

Dr. John Cush RheumNow ( View Tweet)

QD Clinic - RA or Not? Lessons from the clinic. Enough serology, but not enough joints - when does it become RA? https://t.co/akklOklPee

Links:

Dr. John Cush RheumNow ( View Tweet)

We are three weeks out from RheumNow Live. Are you planning on attending? https://t.co/vJlU0Z3Q3x

Links:

Dr. John Cush RheumNow ( View Tweet)

How well do you know this week's rheumatology news?
Take the rheumIQ quiz
Take the RheumIQ Quiz

×